Targeting tumours with genetically enhanced T lymphocytes

被引：412
|
作者：
Sadelain, M
Rivière, I
Brentjens, R
机构：
[1] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA
[2] Mem Sloan Kettering Canc Ctr, Program Immunol, New York, NY 10021 USA
来源：
NATURE REVIEWS CANCER | 2003年 / 3卷 / 01期
关键词：
D O I：
10.1038/nrc971
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
The genetic modification of T lymphocytes is an important approach to investigating normal T-cell biology and to increasing antitumour immunity. A number of genetic strategies aim to increase the recognition of tumour antigens, enhance antitumour activities and prevent T-cell malfunction. T cells can also be engineered to increase safety, as well as to express markers that can be tracked by non-invasive imaging technologies. Genetically modified T cells are therefore proving to be of great value for basic immunology and experimental immunotherapy.
引用
收藏
页码：35 / 45
页数：11
相关论文
共 50 条
  • [21] Genetically modified T lymphocytes: more than just direct effectors
    Lamers, Cor H. J.
    Debets, Reno
    IMMUNOTHERAPY, 2013, 5 (07) : 691 - 694
  • [22] Targeted elimination of prostate cancer by genetically directed human T lymphocytes
    Gade, TPF
    Hassen, W
    Santos, E
    Gunset, G
    Saudemont, A
    Gong, MC
    Brentjens, R
    Zhong, XS
    Stephan, M
    Stefanski, J
    Lyddane, C
    Osborne, JR
    Buchanan, IM
    Hall, SJ
    Heston, WD
    Rivière, I
    Larson, SM
    Koutcher, JA
    Sadelain, M
    CANCER RESEARCH, 2005, 65 (19) : 9080 - 9088
  • [23] T-lymphocytes regulate genetically determined airway hyperresponsiveness in mice
    George T. De Sanctis
    Akihiko Itoh
    Francis H.Y. Green
    Shixin Qin
    Toshihisa Kimura
    James K. Grobholz
    Thomas R. Martin
    Takashi Maki
    Jeffrey M. Drazen
    Nature Medicine, 1997, 3 : 460 - 462
  • [24] Value of measuring subpopulations of T and B lymphocytes in patients with musculoskeletal tumours
    Adnan Zubović
    Margaret Cavanagh
    Brian Hurson
    Archives of Orthopaedic and Trauma Surgery, 2008, 128 : 921 - 929
  • [25] T lymphocytes against solid malignancies: winning ways to defeat tumours
    Caruana, Ignazio
    Simula, Luca
    Locatelli, Franco
    Campello, Silvia
    CELL STRESS, 2018, 2 (08) : 200 - 212
  • [26] Value of measuring subpopulations of T and B lymphocytes in patients with musculoskeletal tumours
    Zubovic, Adnan
    Cavanagh, Margaret
    Hurson, Brian
    ARCHIVES OF ORTHOPAEDIC AND TRAUMA SURGERY, 2008, 128 (09) : 921 - 929
  • [27] SPECIFICITY OF HUMAN T-LYMPHOCYTES IS GENETICALLY REDIRECTED BY CHIMERIC T-BODY RECEPTORS
    KRUGER, M
    BHULLAR, A
    CHIANG, G
    GOODENOW, R
    GREGORY, H
    HARNEY, P
    KAHRS, A
    KILLION, C
    KRAPF, I
    LUNDAK, C
    MCLAUGHLINTAYLOR, E
    REUTER, J
    RODRIQUEZ, E
    SULYA, G
    VERNACHIO, J
    WILLIAMS, A
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1995, : 424 - 424
  • [28] Tracking and targeting T lymphocytes in spinal cord injury.
    Velez, MD
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2003, 225 : U380 - U380
  • [29] Cancer immunotherapy with lymphocytes genetically engineered with T cell receptors for solid cancers
    Chen, Lei
    Qiao, Dongjuan
    Wang, Juntao
    Tian, Geng
    Wang, Mingjun
    IMMUNOLOGY LETTERS, 2019, 216 : 51 - 62
  • [30] In vivo behavior of genetically modified EBV-specific T lymphocytes.
    Heslop, HE
    Ng, CYK
    Smith, CA
    Li, C
    Loftin, S
    Krance, RA
    Brenner, MK
    Rooney, CM
    BLOOD, 1995, 86 (10) : 2461 - 2461
12345